Trivalent GalNAc-DBCO, CAS [[2765060-22-6]]

Produktübersicht

• Artikelname: Trivalent GalNAc-DBCO, CAS [[2765060-22-6]]
• Artikelnummer: TGM-T210528
• Hersteller Artikelnummer: T210528
• Alternativnummer: TGM-T210528-1MG,TGM-T210528-5MG,TGM-T210528-10MG,TGM-T210528-25MG,TGM-T210528-50MG,TGM-T210528-100MG
• Hersteller: TargetMol
• Kategorie: Biochemikalien

Produktbeschreibung

Trivalent GalNAc-DBCO is a synthetic ligand composed of three GalNAc units linked to DBCO. Trivalent GalNAc-DBCO undergoes strain-promoted alkyne-azide cycloaddition (SPAAC) reactions with azide-containing molecules without the need for copper catalysis. Trivalent GalNAc-DBCO binds specifically to the asialoglycoprotein receptor (ASGPR), thereby directing conjugated molecules into hepatocytes for lysosomal degradation through receptor-mediated endocytosis. Trivalent GalNAc-DBCO is extensively applied in studies of liver-targeted drug delivery, targeted degradation strategies, and hepatocyte-specific molecular engineering.

Produkteigenschaften

• Molekulargewicht: 1950.18
• Reinheit: 96.33%
• CAS Nummer: [2765060-22-6]
• Formel: C91H144N12O34
• Target-Kategorie: Transmembrane Glycoprotein

Bilder

T210528